These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14598049)

  • 1. Antibodies and myelination: facts and misacts.
    Pluchino S; Zanotti L; Martino G
    Neurol Sci; 2003 Oct; 24 Suppl 4():S231-3. PubMed ID: 14598049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target.
    Dalakas MC
    Pharmacol Ther; 2006 Oct; 112(1):57-70. PubMed ID: 16644016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflammation and demyelinization: IgIV mode of action].
    Vallat JM; Magy L; Keita M
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 1():3S12-3S16. PubMed ID: 17075522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intravenous immunoglobulin in the treatment of immune-mediated demyelinating diseases of the nervous system.
    Winkelmann A; Zettl UK
    Curr Pharm Des; 2012; 18(29):4570-82. PubMed ID: 22612749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease.
    Calzà L; Fernandez M; Giuliani A; D'Intino G; Pirondi S; Sivilia S; Paradisi M; Desordi N; Giardino L
    Brain Res Brain Res Rev; 2005 Apr; 48(2):339-46. PubMed ID: 15850672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases.
    Stangel M; Toyka KV; Gold R
    Arch Neurol; 1999 Jun; 56(6):661-3. PubMed ID: 10369303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiopathology of natural auto-antibodies: the case for regulation.
    Zelenay S; Moraes Fontes MF; Fesel C; Demengeot J; Coutinho A
    J Autoimmun; 2007 Dec; 29(4):229-35. PubMed ID: 17967665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders?
    Dalakas MC
    Brain; 2004 Dec; 127(Pt 12):2569-71. PubMed ID: 15561895
    [No Abstract]   [Full Text] [Related]  

  • 10. Effector mechanisms in anti-MAG antibody-mediated and other demyelinating neuropathies.
    Latov N; Renaud S
    J Neurol Sci; 2004 May; 220(1-2):127-9. PubMed ID: 15140620
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurologic manifestations of ulcerative colitis.
    Scheid R; Teich N
    Eur J Neurol; 2007 May; 14(5):483-93. PubMed ID: 17437605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
    Comi G; Quattrini A; Fazio R; Roveri L
    Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of autoreactive antibodies.
    Yurasov S; Nussenzweig MC
    Curr Opin Rheumatol; 2007 Sep; 19(5):421-6. PubMed ID: 17762605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demyelinating antibodies in multiple sclerosis.
    Seil FJ
    Ann Neurol; 2000 Dec; 48(6):948. PubMed ID: 11117555
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurosurgical treatment of tremor in anti-myelin-associated glycoprotein neuropathy.
    McMaster J; Gibson G; Castro-Prado F; Vitali A; Honey CR
    Neurology; 2009 Nov; 73(20):1707-8. PubMed ID: 19917996
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurological catastrophes in demyelinating diseases].
    García Domínguez JM; Guzmán de Villoria Lebiedziejewski J
    Neurologia; 2010 Oct; 25 Suppl 1():30-6. PubMed ID: 21129595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical use of auto-antibodies in neurology].
    Cervantes-Arriaga A; Vargas-Cañas S; Rodríguez-Violante M
    Rev Neurol; 2008 Jul 16-31; 47(2):89-98. PubMed ID: 18623008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
    Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
    Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.